Fulcrum Therapeutics Inc. (FULC) Announces Interim Analysis Data from its ReDUX4 Trial in FSHD
Go back to Fulcrum Therapeutics Inc. (FULC) Announces Interim Analysis Data from its ReDUX4 Trial in FSHD| (NASDAQ: FULC) | Delayed: 3.85 +0.08 (2.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.77 | 52 Week High | $ | |||
| Open | $3.69 | 52 Week Low | $ | |||
| Day High | $3.89 | P/E | N/A | |||
| Day Low | $3.69 | EPS | $ | |||
| Volume | 2,813,605 | |||||

